Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes: evidence for normal fibrinolytic state - Harmanci,A.; Kandemir,N.; Dagdelen,S. (J Diabetes Complications, 2006)